Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
US7029655B2 · kind B2 · utility
3Cited by
36References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2001 |
| Grant date | Apr 18, 2006 |
| Priority date | — |
| Expiry date | Dec 21, 2022 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a novel class of magnetic resonance imaging agents that can cross the blood brain barrier and provide accurate magnetic resonance imaging of the brain, especially magnetic resonance images of amyloid deposits associated with Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.